Kiniksa Pharmaceuticals International Plc (KNSA)
47.77
+0.60
(+1.27%)
USD |
NASDAQ |
Feb 20, 16:00
48.29
+0.52
(+1.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap : 3.621B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 24.18M |
| NovoCure Ltd. | 1.272B |
| LivaNova Plc | 3.736B |
| ADMA Biologics, Inc. | 3.832B |
| Alterola Biotech, Inc. | 7.298M |
Market Cap Related Metrics
| PE Ratio | 106.56 |
| PS Ratio | 6.120 |
| Price to Book Value | 6.763 |
| Price to Free Cash Flow | 35.97 |
| Price | 47.77 |
| Earnings Yield | 0.94% |
| Operating PE Ratio | 95.92 |
| Normalized PE Ratio | 106.53 |